FTDI
First Trust Direct Indexing’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-45,538
| Closed | -$8.99M | – | 3 |
|
|
2024
Q3 | $8.99M | Buy |
45,538
+4,601
| +11% | +$909K | 0.48% | 27 |
|
|
2024
Q2 | $7.02M | Buy |
40,937
+6,471
| +19% | +$1.11M | 0.43% | 32 |
|
|
2024
Q1 | $6.28M | Buy |
34,466
+5,915
| +21% | +$1.08M | 0.47% | 32 |
|
|
2023
Q4 | $4.42M | Buy |
28,551
+6,528
| +30% | +$1.01M | 0.4% | 41 |
|
|
2023
Q3 | $3.28M | Buy |
22,023
+7,039
| +47% | +$1.05M | 0.38% | 39 |
|
|
2023
Q2 | $2.02M | Sell |
14,984
-5,279
| -26% | -$711K | 0.22% | 96 |
|
|
2023
Q1 | $3.23M | Buy |
20,263
+3,347
| +20% | +$533K | 0.38% | 41 |
|
|
2022
Q4 | $2.73M | Buy |
16,916
+2,145
| +15% | +$347K | 0.36% | 47 |
|
|
2022
Q3 | $1.98M | Buy |
14,771
+165
| +1% | +$22.1K | 0.29% | 66 |
|
|
2022
Q2 | $2.24M | Buy |
14,606
+289
| +2% | +$44.3K | 0.31% | 61 |
|
|
2022
Q1 | $2.32M | Buy |
14,317
+2,125
| +17% | +$344K | 0.28% | 66 |
|
|
2021
Q4 | $1.65M | Buy |
12,192
+180
| +1% | +$24.4K | 0.21% | 99 |
|
|
2021
Q3 | $1.3M | Buy |
12,012
+209
| +2% | +$22.5K | 0.18% | 121 |
|
|
2021
Q2 | $1.33M | Sell |
11,803
-232
| -2% | -$26.1K | 0.2% | 120 |
|
|
2021
Q1 | $1.3M | Buy |
12,035
+917
| +8% | +$99.2K | 0.35% | 64 |
|
|
2020
Q4 | $1.19M | Buy |
+11,118
| New | +$1.19M | 0.32% | 53 |
|